Marine cyanobacteria—a prolific source of natural products

No abstract is available for this paper.

• Publication year

  2001

• Venue

  Tetrahedron

• Publication date

  2001-11-12

• Fields of study

  Biology, Chemistry, Environmental Science

• Identifiers
  DOI 10.1016/S0040-4020(01)00931-0
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Proteomics in drug discovery.

  2003cited by this paper
• A stereoselective synthesis of (+)-malyngolide via a ring-closing olefin metathesis

  2000cited by this paper
• Hermitamides A and B, toxic malyngamide-type natural products from the marine cyanobacterium Lyngbya majuscula.

  2000cited by this paper
• Apramides A-G, novel lipopeptides from the marine cyanobacterium Lyngbya majuscula.

  2000cited by this paper
• Strategies for discovering drugs from previously unexplored natural products.

  2000cited by this paper
• Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix species.

  2000cited by this paper
• Structural organization of microcystin biosynthesis in Microcystis aeruginosa PCC7806: an integrated peptide-polyketide synthetase system.

  2000cited by this paper
• C-phycocyanin: a potent peroxyl radical scavenger in vivo and in vitro.

  2000cited by this paper
• Total Synthesis and Revision of Absolute Stereochemistry of Antillatoxin, an Ichthyotoxic Cyclic Lipopeptide from Marine Cyanobacterium Lyngbya majuscula

  2000cited by this paper
• Virioplankton: Viruses in Aquatic Ecosystems

  2000cited by this paper
• Lipopeptides as lmmunoadiuvants and lmmunostimulants in Mucosal Immunization

  2000cited by this paper
• Two new malyngamides from a Madagascan Lyngbya majuscula.

  2000cited by this paper
• Novel marine-derived anticancer agents: a phase I clinical, pharmacological, and pharmacodynamic study of dolastatin 10 (NSC 376128) in patients with advanced solid tumors.

  2000cited by this paper
• Delivery of lipids and liposomal proteins to the cytoplasm and Golgi of antigen-presenting cells. mangala.rao@na.amedd.army.mil.

  2000cited by this paper
• Antitumor compounds from tunicates

  2000cited by this paper
• Isolation, structure determination, and biological activity of Lyngbyabellin A from the marine cyanobacterium lyngbya majuscula.

  2000cited by this paper
• Novel extracellular diterpenoids with biological activity from the cyanobacterium Nostoc commune.

  2000cited by this paper
• Determination by High Field NMR Spectroscopy of the Longitudinal Electron Relaxation Rate in Cu(II) Plastocyanin from Anabaena variabilis

  2000cited by this paper
• Multiple Antiviral Activities of Cyanovirin-N: Blocking of Human Immunodeficiency Virus Type 1 gp120 Interaction with CD4 and Coreceptor and Inhibition of Diverse Enveloped Viruses

  2000cited by this paper
• Dolastatin 3 and two novel cyclic peptides from a palauan collection of Lyngbya majuscula.

  2000cited by this paper
• Synthesis of cryptophycin 52 using the sharpless asymmetric dihydroxylation: diol to epoxide transformation optimized for a base-sensitive substrate.

  2000cited by this paper
• Biosynthetic Pathway and Origin of the Chlorinated Methyl Group in Barbamide and Dechlorobarbamide, Metabolites from the Marine Cyanobacterium Lyngbya majuscula

  2000cited by this paper
• First report of microcystin production by picoplanktonic cyanobacteria isolated from a northeast Brazilian drinking water supply

  1999cited by this paper
• Inhibitory metabolites production by the cyanobacterium Fischerella muscicola.

  1999cited by this paper
• Lyngbyastatin 2 and norlyngbyastatin 2, analogues of dolastatin G and nordolastatin G from the marine cyanobacterium Lyngbya majuscula.

  1999cited by this paper
• Biosynthesis of radiolabeled curacin A and its rapid and apparently irreversible binding to the colchicine site of tubulin.

  1999cited by this paper
• Committee on Natural Toxins: Phycotoxins

  1999cited by this paper
• Characterization and synthesis of (−)-7-methoxydodec-4(E)-enoic acid, a novel fatty acid isolated from Lyngbya majuscula

  1999cited by this paper
• Madangolide and laingolide A, two novel macrolides from lyngbya bouillonii (Cyanobacteria)

  1999cited by this paper
• Synthesis of Epiantillatoxin, a Stereoisomer of the Potent Ichthyotoxin from Lyngbya majuscula

  1999cited by this paper
• Lyngbyapeptin A, a modified tetrapeptide from Lyngbya bouillonii (Cyanophyceae)

  1999cited by this paper
• Tumonoic acids, novel metabolites from a cyanobacterial assemblage of Lyngbya majuscula and Schizothrix calcicola.

  1999cited by this paper
• Antibiotic production by the cyanobacteria Oscillatoria angustissima and Calothrix parietina.

  1999cited by this paper
• Tanikolide, a toxic and antifungal lactone from the marine cyanobacterium Lyngbya majuscula.

  1999cited by this paper
• Anabaenopeptins G and H, potent carboxypeptidase A inhibitors from the cyanobacterium Oscillatoria agardhii (NIES-595).

  1999cited by this paper
• Purification and characterization of a hydroperoxidase from the cyanobacterium Synechocystis PCC 6803: identification of its gene by peptide mass mapping using matrix assisted laser desorption ionization time-of-flight mass spectrometry.

  1999cited by this paper
• Induction of apoptosis in mouse thymocytes by microcolin A and its synthetic analog.

  1999cited by this paper
• PRODUCTION OF SECONDARY METABOLITES BY FILAMENTOUS TROPICAL MARINE CYANOBACTERIA: ECOLOGICAL FUNCTIONS OF THE COMPOUNDS

  1999cited by this paper
• The accumulation of cylindrospermopsin from the cyanobacterium Cylindrospermopsis raciborskii in tissues of the Redclaw crayfish Cherax quadricarinatus.

  1999cited by this paper
• Cyanovirin-N Binds to gp120 To Interfere with CD4-Dependent Human Immunodeficiency Virus Type 1 Virion Binding, Fusion, and Infectivity but Does Not Affect the CD4 Binding Site on gp120 or Soluble CD4-Induced Conformational Changes in gp120

  1999cited by this paper
• Serinol-derived malyngamides from an Australian cyanobacterium.

  1999cited by this paper
• Antillatoxin and kalkitoxin, ichthyotoxins from the tropical cyanobacterium Lyngbya majuscula, induce distinct temporal patterns of NMDA receptor-mediated neurotoxicity.

  1999cited by this paper
• Algal blooms on coral reefs: What are the causes?

  1999cited by this paper
• Cyanobacterial PPP Family Protein Phosphatases Possess Multifunctional Capabilities and Are Resistant to Microcystin-LR*

  1999cited by this paper
• A novel extracellular diterpenoid with antibacterial activity from the cyanobacterium Nostoc commune.

  1999cited by this paper
• Bioprocess Intensification for Production of Novel Marine Bacterial Antibiotics Through Bioreactor Operation and Design

  1999cited by this paper
• Multiple stressors on coral reefs: A long ‐term perspective

  1999cited by this paper
• Analysis of aplidine (dehydrodidemnin B), a new marine-derived depsipeptide, in rat biological fluids by liquid chromatography-tandem mass spectrometry.

  1999cited by this paper
• Synthesis of Dolastatin 15 mimetic peptoids.

  1998cited by this paper
• Carmabins A and B, new lipopeptides from the Caribbean cyanobacterium Lyngbya majuscula.

  1998cited by this paper
• Structure-activity analysis of the interaction of curacin A, the potent colchicine site antimitotic agent, with tubulin and effects of analogs on the growth of MCF-7 breast cancer cells.

  1998cited by this paper
• Action of the allelochemical, fischerellin A, on photosystem II.

  1998cited by this paper
• Dietary preferences of the opisthobranch mollusc Stylocheilus longicauda for secondary metabolites produced by the tropical cyanobacterium Lyngbya majuscula

  1998cited by this paper
• Tenuecyclamides A-D, cyclic hexapeptides from the cyanobacterium Nostoc spongiaeforme var. tenue.

  1998cited by this paper
• Chemical defense of a marine cyanobacterial bloom

  1998cited by this paper
• Curacin D, an antimitotic agent from the marine cyanobacterium Lyngbya majuscula.

  1998cited by this paper
• More Peptides and Other Diverse Constituents of the Marine Mollusk Philinopsis speciosa

  1998cited by this paper
• Adjuvant lipopeptide interaction with model membranes.

  1998cited by this paper
• Cyanobacteria - a novel source of pharmaceuticals.

  1998cited by this paper
• Isolation of a new okadaic acid analogue from phytoplankton implicated in diarrhetic shellfish poisoning.

  1998cited by this paper
• Symplostatin 1: A dolastatin 10 analogue from the marine cyanobacterium Symploca hydnoides.

  1998cited by this paper
• Two (Z)-dehydrobutyrine-containing microcystins from a hepatotoxic bloom of Oscillatoria agardhii from Soulseat Loch, Scotland.

  1998cited by this paper
• Isolation, structure determination, and biological activity of dolastatin 12 and lyngbyastatin 1 from Lyngbya majuscula/Schizothrix calcicola cyanobacterial assemblages.

  1998cited by this paper
• Kalkipyrone, a toxic gamma-pyrone from an assemblage of the marine cyanobacteria Lyngbya majuscula and Tolypothrix sp.

  1998cited by this paper
• The structure of the exocellular polysaccharide from the cyanobacterium Cyanospira capsulata.

  1998cited by this paper
• Grenadadiene and grenadamide, cyclopropyl-containing fatty acid metabolites from the marine cyanobacterium Lyngbya majuscula.

  1998cited by this paper
• Total Synthesis of (-)-Muscoride A: A Novel Bis-Oxazole Based Alkaloid from the Cyanobacterium Nostoc muscorum

  1998cited by this paper
• Biosynthesis of the marine cyanobacterial metabolite barbamide. 1. Origin of the trichloromethyl group

  1998cited by this paper
• A CONCISE TOTAL SYNTHESIS OF (+)-CURACIN A, A NOVEL CYCLOPROPYL-SUBSTITUTED THIAZOLINE FROM THE CYANOBACTERIUM LYNGBYA, MAJUSCULA

  1998cited by this paper
• Pitiamide A, a new chlorinated lipid from a mixed marine cyanobacterial assemblage

  1997cited by this paper
• A new tactic for diastereo- and enantiocontrolled synthesis of (−)-malyngolide via catalytic meso-asymmetrization

  1997cited by this paper
• Spirulina platensis inhibits anaphylactic reaction.

  1997cited by this paper
• Comparative study of toxic and non-toxic cyanobacterial products: Novel peptides from toxic Nodularia spumigena AV1

  1997cited by this paper
• Natural products in drug discovery and development.

  1997cited by this paper
• Lyngbyaloside, a novel 2,3,4-tri-O-methyl-6-deoxy-α-mannopyranoside macrolide from Lyngbya bouillonii (Cyanobacteria)

  1997cited by this paper
• THREE NEW MALYNGAMIDES FROM THE MARINE CYANOBACTERIUM LYNGBYA MAJUSCULA

  1997cited by this paper
• Antiproliferative and immunosuppressive properties of microcolin A, a marine-derived lipopeptide.

  1997cited by this paper
• Detection of an anatoxin-a(s)-like anticholinesterase in natural blooms and cultures of cyanobacteria/blue-green algae from Danish lakes and in the stomach contents of poisoned birds.

  1997cited by this paper
• Two quinoline alkaloids from the Caribbean cyanobacterium Lyngbya majuscula.

  1997cited by this paper
• A comparison of selected mRNA and protein abundances in human liver

  1997cited by this paper
• Evidence for paralytic shellfish poisons in the freshwater cyanobacterium Lyngbya wollei (Farlow ex Gomont) comb. nov

  1997cited by this paper
• New acylated sulfoglycolipids and digalactolipids and related known glycolipids from cyanobacteria with a potential to inhibit the reverse transcriptase of HIV-1.

  1997cited by this paper
• Bastadin 20 and bastadin O-sulfate esters from Ianthella basta: novel modulators of the Ry1R FKBP12 receptor complex.

  1996cited by this paper
• A Natural Sulfated Polysaccharide, Calcium Spirulan, Isolated from Spirulina platensis: In Vitro and ex Vivo Evaluation of Anti-Herpes Simplex Virus and Anti-Human Immunodeficiency Virus Activities

  1996cited by this paper
• EVIDENCE THAT MICROCYSTIN IS A THIO‐TEMPLATE PRODUCT 1

  1996cited by this paper
• Kulolide: A cytotoxic depsipeptide from a cephalaspidean mollusk, Philinopsis speciosa

  1996cited by this paper
• Pharmacognosy and Pharmacobiotechnology

  1996cited by this paper
• Bacterial triterpenoids of the hopane series from the prochlorophyte Prochlorothrix hollandica and their intracellular localization.

  1996cited by this paper
• Structure−Activity Relationships of the Didemnins1,2

  1996cited by this paper
• Novel Violet Pigment, Nostocine A, an Extracellular Metabolite from Cyanobacterium Nostoc spongiaeforme

  1996cited by this paper
• Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean cyanobacterium Lyngbya majuscula.

  1996cited by this paper
• Dendroamides, new cyclic hexapeptides from a blue-green alga. Multidrug-resistance reversing activity of dendroamide A.

  1996cited by this paper
• The Search for New Antitumor Drugs from Blue-Green Algae

  1996cited by this paper
• SYNTHETIC STUDIES OF MICROCOLIN B

  1996cited by this paper
• Microtubule effects of welwistatin, a cyanobacterial indolinone that circumvents multiple drug resistance.

  1996cited by this paper
• Novel bioactive secondary metabolites from the marine cyanobacterium Lyngbya majuscula

  1996cited by this paper
• Oscillapeptin G, a tyrosinase inhibitor from toxic Oscillatoria agardhii.

  1996cited by this paper
• Marine Biodiversity and the Medicine Cabinet: The Status of New Drugs from Marine Organisms

  1996cited by this paper
• Total Synthesis of (-)-Muscoride A.

  1996cited by this paper
• Antiproliferative effect of dehydrodidemnin B (DDB), a depsipeptide isolated from Mediterranean tunicates.

  1996cited by this paper

• Description of a New Marine Cyanobacterium from the Cabo Verde Archipelago: Pigments Profile and Biotechnological Potential of Salileptolyngbya caboverdiana sp. nov.

  2026cites this paper
• Genetic Instability in Synechococcus sp. PCC 7002 under Different Promoters

  2026cites this paper
• Bioactive Peptides from Microalgae and Cyanobacteria and Their Possible Mechanisms of Action

  2025cites this paper
• Genomic and chemical characterization of cytotoxic Ahp-cyclodepsipeptides from Phormidium using Thamnocephalus platyurus bioassay.

  2025cites this paper
• Can the Cyanobacterium Nostoc commune Exert In Vitro Biocontrol on Fusarium oxysporum, Causal Agent of Wilt in Banana (Musa AAB)?

  2025cites this paper
• Tolypothrix Strains (Cyanobacteria) as a Source of Bioactive Compounds with Anticancer, Antioxidant and Anti-Inflammatory Activity

  2025cites this paper
• Resilient pioneers: The ecological role of cyanobacteria in desert ecosystems

  2025cites this paper
• Biosynthesis of guanidine-containing natural products in cyanobacteria

  2025cites this paper
• Genomic complexity and evolutionary diversification of a novel cyanobacterium from coral reef ecosystems

  2025cites this paper
• Unraveling the Toxicity of a Non-Microcystin-Producing Strain (CCIBt3106) of Microcystis aeruginosa: Ecotoxicological Effects on Aquatic Invertebrates

  2025cites this paper
• Pollutant Gases to Algal Animal Feed: Impacts of Poultry House Exhaust Air on Amino Acid Profile of Algae

  2024cites this paper
• Evaluating stress resilience of cyanobacteria through flow cytometry and fluorescent viability assessment

  2024cites this paper
• Extracts of the cyanobacteria Microcystis flos-aquae contain potent anti-Trypanosoma compounds

  2024cites this paper
• Genomic Insights into the Taxonomy and Metabolism of the Cyanobacterium Pannus brasiliensis CCIBt3594

  2024cites this paper
• Environmental Factors Modulate Saxitoxins (STXs) Production in Toxic Dinoflagellate Alexandrium: An Updated Review of STXs and Synthesis Gene Aspects

  2024cites this paper
• A critical review of current research on cyanobacterial cells and associated toxins in aquatic environments: Occurrence, impact, and treatment methods

  2024cites this paper
• Investigation on the insecticidal activities of cyanobacterial extracts as an alternative source for the management of fall armyworm, Spodoptera frugiperda (J. E. Smith) (Lepidoptera: Noctuidae)

  2024cites this paper
• Ecological Features and Adaptive Capabilities of Cyanobacteria in Desert Ecosystems: A Review

  2024cites this paper
• Lesser-Known Cyanotoxins: A Comprehensive Review of Their Health and Environmental Impacts

  2024cites this paper
• Biomedical engineering utilizing living photosynthetic cyanobacteria and microalgae: Current status and future prospects

  2024cites this paper
• Antimicrobial peptides (AMPs) from microalgae as an alternative to conventional antibiotics in aquaculture

  2024cites this paper
• Isolation and Total Synthesis of PM170453, a New Cyclic Depsipeptide Isolated from Lyngbya sp.

  2024cites this paper
• Photobioreactor systems for mitigating ammonia and carbon dioxide from a broiler house.

  2024cites this paper
• Mangrove Associated Cyanobacteria Phormidium tenue from Parangipettai Environment Collection Isolation Identification and Elemental Analysis

  2024cites this paper
• Toxicity and enzymatic inhibitory action of Spirulina sp. and Nostoc muscorum extracts on detoxifying enzymes in Spodoptera frugiperda (J. E. Smith) (Noctuidae: Lepidoptera)

  2024cites this paper
• Physiological and genomic analysis of Limnospira sp. AlgLouSa11 isolated from Tamanrasset, Algeria

  2024cites this paper
• In vitro study of antioxidant, antimicrobial, and anticancer activities of two selected cyanobacteria found across Odisha coast, India

  2023cites this paper
• Identification of a New Compound (4-Fluoro-2-Trifluoromethyl Imidazole) Extracted from a New Halophilic Bacillus aquimaris Strain Persiangulf TA2 Isolated from the Northern Persian Gulf with Broad-Spectrum Antimicrobial Effect

  2023cites this paper
• Nutritional Value of Microalgae and Cyanobacteria Produced with Batch and Continuous Cultivation: Potential Use as Feed Material in Poultry Nutrition

  2023cites this paper
• Insight to biotechnological utility of phycochemicals from cyanobacterium Anabaena sp.: An overview.

  2023cites this paper
• Wastewater as a Source of Productive Water, Biomass, and Energy at Low Cost Against the Respective Scarcities in the Present and the Future in African Countries

  2023cites this paper
• Cyanobacteria Natural Products as Sources for Future Directions in Antibiotic Drug Discovery

  2023influential citation
• Cyanometabolites: molecules with immense antiviral potential

  2023cites this paper
• Culture supernatants of the cyanobacterium Trichormus sp. promote the growth of the grass Polypogon australis Brong: Role of P and Mn

  2023cites this paper
• Nanosynthesis, phycochemical constituents, and pharmacological properties of cyanobacterium Oscillatoria sp.

  2023cites this paper
• Antifouling activity of microorganisms associated with the marine organisms

  2023cites this paper
• Algal-fungal interactions and biomass production in wastewater treatment: Current status and future perspectives

  2023cites this paper
• An integrative review of the biology and chemistry of lichens and their ecological, ethnopharmacological, pharmaceutical and therapeutic potential

  2023cites this paper
• Naturally occurring emerging contaminants: Where to hide?

  2023cites this paper
• Antimicrobial peptides derived from microalgae for combating antibiotic resistance: Current status and prospects

  2023cites this paper
• The Immune System of Marine Organisms as Source for Drugs against Infectious Diseases

  2022cites this paper
• Nostoc muscorum is a novel source of microalgal lectins with potent antiviral activity against herpes simplex type-1.

  2022cites this paper
• Toxic Effects and Tumor Promotion Activity of Marine Phytoplankton Toxins: A Review

  2022cites this paper
• Bioprospecting for bioactive compounds in microalgae: Antimicrobial compounds.

  2022cites this paper
• Insight into the Potential Cyanobacterial Metabolites and their Screening Strategies

  2022cites this paper
• Application of cyanobacteria in soil health and rhizospheric engineering

  2022cites this paper
• Identification and characterization of the novel bioactive compounds from microalgae and cyanobacteria for pharmaceutical and nutraceutical applications

  2022influential citation
• Convoluted role of cyanobacteria as biofertilizer: an insight of sustainable agriculture

  2022cites this paper
• Role of microalgal metabolites in controlling quorum-sensing-regulated biofilm

  2022cites this paper
• Recent progression of cyanobacteria and their pharmaceutical utility: an update

  2022influential citation
• Molecular characterization of local cyanobacterial isolates using 16S rRNA, rpoB, and nif  H biomarkers

  2022cites this paper
• Biosynthesis of the Unusual Carbon Skeleton of Nocuolin A

  2022cites this paper
• Impact of high pressure treatment on shelf life and microbial profile of wild harvested Ascophyllum nodosum and aquacultured Alaria esculenta during storage

  2022cites this paper
• Anti-Infective Secondary Metabolites of the Marine Cyanobacterium Lyngbya Morphotype between 1979 and 2022

  2022cites this paper
• Therapeutic potential of marine macrolides: An overview from 1990 to 2022.

  2022cites this paper
• Soil substrate culturing approaches recover diverse members of Actinomycetota from desert soils of Herring Island, East Antarctica

  2022cites this paper
• Metabolic composition of the cyanobacterium Nostoc muscorum as a function of culture time: A 1H NMR metabolomics study

  2022influential citation
• Cyanobacterial and microalgal bioremediation: an efficient and eco-friendly approach toward industrial wastewater treatment and value-addition

  2022cites this paper
• POTENT PHARMACEUTICAL PRODUCTS FROM AQUATIC PLANTS – REVIEW

  2021cites this paper
• Exploiting the beneficial properties of microalgae for food and feed use

  2021cites this paper
• Bioprospecting microalgae and cyanobacteria for biopharmaceutical applications

  2021cites this paper
• Cyanobacterial natural products as sources for antiviral drug discovery against COVID-19

  2021influential citation
• Heterologous production of a cyanobacterial bacteriocin with potent antibacterial activity

  2021cites this paper
• Mining of Cyanobacterial Genomes Indicates Natural Product Biosynthetic Gene Clusters Located in Conjugative Plasmids

  2021cites this paper
• Cyanobacterial photoprotective compounds: characterization and utilization in human welfare

  2021cites this paper
• Sequestration and Cyanobacterial Diet Preferences in the Opisthobranch Molluscs Dolabrifera nicaraguana and Stylocheilus rickettsi

  2021cites this paper
• Seasonal Nutritional Profile of Gelidium corneum (Rhodophyta, Gelidiaceae) from the Center of Portugal

  2021cites this paper
• Landscape of natural product diversity in land-plants as source for anticancer molecules

  2021cites this paper
• Effects of Cyanobacterial Metabolites on Other Bacterial Phyla and in the Morphogenesis, Viability, and Biochemistry of Eukaryotes

  2021cites this paper
• Cytotoxic and Antibiotic Properties of Cyanobacterial Extracts

  2021cites this paper
• Bioactive molecules from microalgae and constraints in commercialization

  2021cites this paper
• Metabolic pathways for production of anticancer compounds in cyanobacteria

  2021cites this paper
• Potential of Cyanobacteria in Wound Healing

  2021cites this paper
• Studies on Antibacterial Activity of a Cyanobacterium Tolypothrix fragilis (Gardner) Geitler

  2021cites this paper
• Microalgal-based feed: promising alternative feedstocks for livestock and poultry production

  2021cites this paper
• Viral inhibitors derived from macroalgae, microalgae, and cyanobacteria: A review of antiviral potential throughout pathogenesis

  2021cites this paper
• Evaluation of three photosynthetic species smaller than ten microns as possible standard test organisms of ultraviolet-based ballast water treatment.

  2021cites this paper
• Antibacterial and antiviral metabolites from cyanobacteria: Their application and their impact on human health

  2021cites this paper
• Evaluation of the probiotic potential of Streptomyces antibioticus and Bacillus cereus on growth performance of freshwater catfish Heteropneustes fossilis

  2021cites this paper
• Cyanobacteria-based microbial cell factories for production of industrial products

  2021cites this paper
• Role of cyanobacteria in green remediation

  2021cites this paper
• EVALUATION OF ANTIBACTERIAL ACTIVITY OF A CYANOBACTERIUM SCYTONEMA SCHMIDTII GOM

  2021cites this paper
• Introduction to cyanobacteria

  2021cites this paper
• The Promotive Effect of Cyanobacteria and Chlorella sp. Foliar Biofertilization on Growth and Metabolic Activities of Willow (Salix viminalis L.) Plants as Feedstock Production, Solid Biofuel and Biochar as C Carrier for Fertilizers via Torrefaction Process

  2021cites this paper
• Industrial Applications of Cyanobacteria

  2021cites this paper
• Plant-cyanobacteria interactions: Beneficial and harmful effects of cyanobacterial bioactive compounds on soil-plant systems and subsequent risk to animal and human health.

  2021cites this paper
• Brazilian Coast: A Significant Gap in the Knowledge of Cyanobacteria and Their Applications

  2021cites this paper
• Recent advances in the integrated biorefinery concept for the valorization of algal biomass through sustainable routes

  2021cites this paper
• The current state of knowledge on taxonomy, modulating factors, ecological roles, and mode of action of phytoplankton allelochemicals.

  2021cites this paper
• Identification of antifungal and antibacterial biomolecules from a cyanobacterium, Arthrospira platensis

  2021cites this paper
• Cyanobacteria as Sustainable Microbiome for Agricultural Industries

  2021cites this paper
• Cyanobacteria—From the Oceans to the Potential Biotechnological and Biomedical Applications

  2021cites this paper
• Microalgal Cell Biofactory—Therapeutic, Nutraceutical and Functional Food Applications

  2021cites this paper
• d-Peptidase Activity in a Marine Mollusk Detoxifies a Nonribosomal Cyclic Lipopeptide: An Ecological Model to Study Antibiotic Resistance.

  2021cites this paper
• Review POTENT PHARMACEUTICAL PRODUCTS FROM AQUATIC PLANTS – REVIEW

  2021cites this paper
• Allelopathy and allelochemicals from microalgae: An innovative source for bio-herbicidal compounds and biocontrol research

  2021cites this paper
• The “Bright Side” of Cyanobacteria: Revising the Nuisance Potential and Prospecting Innovative Biotechnology-Based Solutions to Integrate Water Management Programs

  2021cites this paper
• Terrestrische Cyanobakterien als Quelle für antimikrobielle Wirkstoffe

  2020cites this paper
• Algal Metabolites and Phyco-Medicine

  2020cites this paper
• Biotechnological Applications of Microalgal Oleaginous Compounds: Current Trends on Microalgal Bioprocessing of Products

  2020cites this paper